Strategic Research Partner of the American Bar Association's Section of International LawThe Queen's Award for Enterpise 2012

Thomas H Beck

Thomas H Beck
Office:
787 Seventh Avenue
10019
City:
New York
State:
New York
Country:
USA
Tel:
+1 212 839 5940
Fax:
+1 212 839 5599

Biography • Patents - Lawyers

Thomas H Beck leads the New York IP group, and focuses on complex chemical and pharmaceutical litigation matters. In 2012, Mr Beck’s team won a two-week jury trial for Sunovion in Hatch-Waxman litigation against Mylan concerning the asthma drug Xopenex (levalbuterol), winning lost profits, reasonable royalty and a finding of wilful infringement. The National Law Journal listed that verdict in the top 100 jury verdicts for 2012, and it was also in the top 20 IP jury awards for 2012.

He is also lead counsel for Sunovion in Hatch-Waxman litigation against Actavis concerning Xopenex HFA. The case was tried in November 2014, and a decision is expected in June 2015. His team prevailed in the Markman rulings in March and June 2014, as well as in the Court's pretrial rulings.

He was recently lead counsel for Noven Pharmaceuticals in Hatch-Waxman litigation against Watson concerning the Daytrana transdermal patch treatment for ADHD, which settled favourably on the eve of trial.

Mr Beck was lead counsel for ConvaTec in litigation concerning medical devices providing negative pressure wound therapy, and for LSI in litigation against Xilinx involving numerous patents relating to programmable field gate arrays and related circuits. Mr Beck has also led several successful multimillion-dollar mediation and arbitration efforts, including Marvell v Agere which involved 802.11 wifi networks.

Mr Beck received his JD from Harvard Law School in 1979 and his BS (with honours) from North Dakota State University in 1975.

This biography is an extract from Who's Who Legal: Patents which can be purchased from our Shop.

Biography • Life Sciences - Patent Litigation

Thomas H Beck is the head of Sidley’s New York IP group, and focuses on complex chemical and pharmaceutical litigation matters. In February 2012 Mr Beck won a two-week jury trial for Sunovion in Hatch-Waxman litigation against Mylan concerning the asthma medication Xopenex (levalbuterol), winning lost profits, reasonable royalty and a finding of wilful infringement. The National Law Journal listed that verdict in the top 100 jury verdicts for 2012, and it was also in the top 20 IP jury awards for 2012. He is lead counsel for Noven Pharmaceuticals in Hatch-Waxman litigation against Watson concerning the Daytrana transdermal patch treatment for ADHD, and he is also lead counsel for ConvaTec in litigation brought by KCI and Wake Forest University concerning negative pressure wound therapy. He was recently lead IP counsel for LSI in litigation against Xilinx involving numerous patents relating to programmable field gate arrays and related circuits. He was lead counsel in several successful multimillion-dollar mediation and arbitration efforts, including Marvell v Agere which involved 802.11 Wi-Fi networks.

Mr Beck was lead or co-lead counsel for Eli Lilly and Company, Schering-Plough, GlaxoSmithKline, Bristol-Myers Squibb, Sanofi-Aventis and others on matters such as the ADHD drug atomoxetine, the anticholesterol drug ezetimibe, the antidiabetic drug rosiglitazone maleate, the anti-cancer drug paclitaxel and the platelet inhibitor agent clopidogrel bisulfate. He was lead counsel for Bristol in the Bristol v RPR case, in which RPR’s patent claims were found unenforceable; the SDNY awarded Bristol’s attorney fees for the six-year battle.

This biography is an extract from Who's Who Legal: Life Sciences which can be purchased from our Shop.

Follow us on LinkedIn

Practice Areas

Firms

Browse Firms

Search Firms

The Who's Who Legal 100

Awards

News & Features

Special Reports

Events

Shop

About Us

It is not possible to buy entry into any Who's Who Legal publication

Nominees have been selected based upon comprehensive, independent survey work with both general counsel and private practice lawyers worldwide. Only specialists who have met independent international research criteria are listed.

Copyright © 2015 Law Business Research Ltd. All rights reserved. | http://www.lbresearch.com

87 Lancaster Road, London, W11 1QQ, UK | Tel: +44 20 7908 1180 / Fax: +44 207 229 6910

http://www.whoswholegal.com | editorial@whoswholegal.com

Law Business Research Ltd

87 Lancaster Road, London
W11 1QQ, UK